Page 2 - க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark Life Sciences’ Rs 1,600-cr IPO may open next week Glenmark Life Sciences’ IPO comprises a fresh issue of Rs 1,160 crore and a sale of 7.3 million shares by promoter Glenmark Pharmaceuticals Glenmark Life Sciences filed for an updated DRHP last week BusinessToday.In Updated Jul 19, 2021, 9:44 AM IST Glenmark Life Sciences (GLS), a unit of Glenmark Pharmaceuticals is among a long list of companies queuing for an initial public offering. The company filed for an updated draft red herring prospectus (DRHP) last week. GLS’ Rs 1,600-crore IPO is likely to be launched later in July. While Glemark has not officially said anything on the matter, sources told The Economic Times that they are aiming to hit the primary markets next week.

Tatva chintan pharmaGlenmark life sciencesExchange board of indiaGlenmark pharmaceuticalsEconomic timesClean scienceTatva chintanGlenmark life sciences limitedGlenmark pharmaceuticals limitedExchange boardதத்வா சிந்தன் பார்மாக்ளேண்மர்க் வாழ்க்கை அறிவியல்பரிமாற்றம் பலகை ஆஃப் இந்தியாக்ளேண்மர்க் மருந்துகள்பொருளாதார முறைசுத்தமான அறிவியல்